Skip to main content
Erschienen in: Drug Safety 6/2008

01.06.2008 | Original Research Article

Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to a Geriatric Unit

A Prospective Study of 1756 Patients

verfasst von: Marilisa Franceschi, Carlo Scarcelli, Valeria Niro, Davide Seripa, Anna Maria Pazienza, Giovanni Pepe, Anna Maria Colusso, Luigi Pacilli, Dr Alberto Pilotto

Erschienen in: Drug Safety | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Background: Drug use increases with advancing age, and in older patients it is associated with an increase in adverse drug reactions (ADRs). ADRs are a primary cause of morbidity and mortality worldwide.
Objectives: To evaluate the prevalence, clinical characteristics and avoidability of ADR-related hospital admissions in elderly patients.
Methods: From November 2004 to December 2005, all patients aged ≥65 years consecutively admitted to the Geriatric Unit of the Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo in Italy, were evaluated for enrolment in the study. ADRs were defined according to the WHO Adverse Reaction Terminology system. Drugs were classified according to Anatomical Therapeutic Chemical classification system. The Naranjo algorithm was used to evaluate the relationship between drug use and the ADR (definite, probable, possible or doubtful) and Hallas criteria were used to evaluate the avoidability of the ADR (definitely avoidable, possibly avoidable or unavoidable). All cases of a suspected ADR were discussed by a team trained in drug safety, including three geriatricians, one clinical pharmacologist and one pharmacist. Only cases of an ADR with an agreement ≥80% were included.
Results: Of the 1756 patients observed, 102 (5.8%, 42 males, 60 females, mean age 76.5 ± 7.4 years, range 65–93 years) showed certain (6.8%) or probable (91.2%) ADR-related hospitalization. Gastrointestinal disorders (48 patients, 47.1%); platelet, bleeding and clotting disorders (20 patients, 19.6%); and cardiovascular disorders (13 patients, 12.7%) were the most frequent ADRs. NSAIDs (23.5%), oral anticoagulants (20.6%), low-dose aspirin (acetylsalicylic acid) [13.7%] and digoxin (12.7%) were the drugs most frequently involved in ADRs. Of the ADRs, 45.1% were defined as definitely avoidable, 31.4% as possibly avoidable, 18.6% as unavoidable and 4.9% as unclassifiable. Of 78 patients with definitely or possibly avoidable ADRs, 17 patients (21.8%) had received an inappropriate prescription, 29 patients (37.2%) had not received a prescription for an effective gastroprotective drug concomitantly with NSAID or low-dose aspirin treatment and 32 patients (41%) were not monitored during drug treatment.
Conclusion: In the elderly, almost 6% of hospitalizations are ADR related. Most of these ADRs are potentially avoidable. Strategies that reduce inappropriate prescriptions and monitoring errors, as well as improving active prevention of ADRs, are needed in elderly subjects.
Literatur
1.
Zurück zum Zitat Pilotto A, Franceschi M, Vitale D, et al. on behalf of FIRI and SOFIA Project Investigators. Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms. Eur J Clin Pharmacol 2006; 62: 65–72PubMedCrossRef Pilotto A, Franceschi M, Vitale D, et al. on behalf of FIRI and SOFIA Project Investigators. Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms. Eur J Clin Pharmacol 2006; 62: 65–72PubMedCrossRef
2.
Zurück zum Zitat Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8PubMedCrossRef Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8PubMedCrossRef
3.
Zurück zum Zitat Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231–9PubMedCrossRef Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231–9PubMedCrossRef
4.
Zurück zum Zitat Mannesse CK, Derkx FH, de Ridder MA, et al. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–8PubMedCrossRef Mannesse CK, Derkx FH, de Ridder MA, et al. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–8PubMedCrossRef
5.
Zurück zum Zitat Cunningham G, Dodd TRP, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82PubMedCrossRef Cunningham G, Dodd TRP, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82PubMedCrossRef
6.
Zurück zum Zitat Mannesse CK, Derkx FHM, De Ridder MAJ, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9PubMedCrossRef Mannesse CK, Derkx FHM, De Ridder MAJ, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9PubMedCrossRef
7.
Zurück zum Zitat Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admission in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8PubMed Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admission in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8PubMed
8.
Zurück zum Zitat Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15–9PubMedCrossRef Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15–9PubMedCrossRef
9.
Zurück zum Zitat Ghandi TK, Burstin HR, Cook F, et al. Drug complication in outpatients. J Gen Intern Med 2000; 15: 149–54CrossRef Ghandi TK, Burstin HR, Cook F, et al. Drug complication in outpatients. J Gen Intern Med 2000; 15: 149–54CrossRef
10.
Zurück zum Zitat Gurwitz JH, Field TS, Harrold LR, et al. Incidence and prevent-ability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16PubMedCrossRef Gurwitz JH, Field TS, Harrold LR, et al. Incidence and prevent-ability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16PubMedCrossRef
11.
Zurück zum Zitat Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing home. Am J Med 2000; 109: 87–94PubMedCrossRef Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing home. Am J Med 2000; 109: 87–94PubMedCrossRef
12.
Zurück zum Zitat Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 1238–48PubMedCrossRef Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 1238–48PubMedCrossRef
13.
Zurück zum Zitat Rubenstein LZ, Joseph T. Freeman award lecture: comprehensive geriatric assessment: from miracle to reality. J Gerontol A Biol Sci Med Sci 2004; 59: 473–7PubMedCrossRef Rubenstein LZ, Joseph T. Freeman award lecture: comprehensive geriatric assessment: from miracle to reality. J Gerontol A Biol Sci Med Sci 2004; 59: 473–7PubMedCrossRef
14.
Zurück zum Zitat L’informatore farmaceutico 2004. OEMF International, Milano 2002. Guidelines for ATC-Classification. Uppsala: NLN-publication No.16 Nordic Council on Medicines, 1985 L’informatore farmaceutico 2004. OEMF International, Milano 2002. Guidelines for ATC-Classification. Uppsala: NLN-publication No.16 Nordic Council on Medicines, 1985
15.
Zurück zum Zitat Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef
16.
Zurück zum Zitat World Health Organization. International drug monitoring: the role of national centres. WHO technical Report series. 498. Geneva: World Health Organization, 1972 World Health Organization. International drug monitoring: the role of national centres. WHO technical Report series. 498. Geneva: World Health Organization, 1972
18.
Zurück zum Zitat Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef
19.
Zurück zum Zitat Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90PubMedCrossRef Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90PubMedCrossRef
20.
Zurück zum Zitat Katz S, Downs TD, Cash HR, et al. Progress in the development of an index of ADL. Gerontologist 1970; 10: 20–30PubMedCrossRef Katz S, Downs TD, Cash HR, et al. Progress in the development of an index of ADL. Gerontologist 1970; 10: 20–30PubMedCrossRef
21.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–86PubMedCrossRef Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–86PubMedCrossRef
22.
Zurück zum Zitat Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433–41PubMed Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433–41PubMed
23.
Zurück zum Zitat Linn B, Linn M, Gurel L. The cumulative illness rating scale. J Am Geriatr Soc 1968; 16: 622–6PubMed Linn B, Linn M, Gurel L. The cumulative illness rating scale. J Am Geriatr Soc 1968; 16: 622–6PubMed
24.
Zurück zum Zitat Guigoz Y, Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999; 1: 3–11PubMedCrossRef Guigoz Y, Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999; 1: 3–11PubMedCrossRef
25.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN, et al. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN, et al. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef
26.
Zurück zum Zitat Beijer HJM, Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46–54PubMedCrossRef Beijer HJM, Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46–54PubMedCrossRef
27.
Zurück zum Zitat Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–77PubMedCrossRef Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–77PubMedCrossRef
28.
Zurück zum Zitat Vila A, San Jose A, Roure C, et al. Prospective multicenter study of adverse drug in hospitalized elderly patients. Med Clin 2003; 120: 613–8CrossRef Vila A, San Jose A, Roure C, et al. Prospective multicenter study of adverse drug in hospitalized elderly patients. Med Clin 2003; 120: 613–8CrossRef
29.
Zurück zum Zitat Pilotto A, Franceschi M, Vitale DF, et al. on behalf of F.I.R.I. (Fondazione Italiana Ricerca sull’Invecchiamento and the SOFIA Project Investigators). Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs. Aliment Pharmacol Ther 2005; 22: 147–55PubMedCrossRef Pilotto A, Franceschi M, Vitale DF, et al. on behalf of F.I.R.I. (Fondazione Italiana Ricerca sull’Invecchiamento and the SOFIA Project Investigators). Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs. Aliment Pharmacol Ther 2005; 22: 147–55PubMedCrossRef
30.
Zurück zum Zitat Pilotto A, Franceschi M, Leandro G, et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004; 20: 1091–7PubMedCrossRef Pilotto A, Franceschi M, Leandro G, et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004; 20: 1091–7PubMedCrossRef
31.
Zurück zum Zitat Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly acute and chronic users of aspirin and other non-steroidal antiinflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15: 494–9PubMed Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly acute and chronic users of aspirin and other non-steroidal antiinflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15: 494–9PubMed
32.
Zurück zum Zitat Torn M, Bollen Ward LEM, van der Meer FJM, et al. Risk of oral anticoagulant therapy with increasing age. Arch Intern Med 2005; 165: 527–32CrossRef Torn M, Bollen Ward LEM, van der Meer FJM, et al. Risk of oral anticoagulant therapy with increasing age. Arch Intern Med 2005; 165: 527–32CrossRef
33.
Zurück zum Zitat Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325: 1073–5PubMedCrossRef Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325: 1073–5PubMedCrossRef
34.
Zurück zum Zitat Fihn SD, McDonell MB, Vermes D, et al. A computerised intervention to improve timing of outpatient follow-up: a multicenter randomised trial in patients treated with warfarin. J Gen Intern Med 1994; 9: 131–9PubMedCrossRef Fihn SD, McDonell MB, Vermes D, et al. A computerised intervention to improve timing of outpatient follow-up: a multicenter randomised trial in patients treated with warfarin. J Gen Intern Med 1994; 9: 131–9PubMedCrossRef
35.
Zurück zum Zitat Fitzmaurice DA, Hobbs FD, Murray ET, et al. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomised, controlled trial. Arch Intern Med 2000; 160: 2343–8PubMedCrossRef Fitzmaurice DA, Hobbs FD, Murray ET, et al. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomised, controlled trial. Arch Intern Med 2000; 160: 2343–8PubMedCrossRef
36.
Zurück zum Zitat Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled 556 trial. Working group for the study of patient self-management of oral anti-coagulation. JAMA 1999; 281: 145–50PubMedCrossRef Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled 556 trial. Working group for the study of patient self-management of oral anti-coagulation. JAMA 1999; 281: 145–50PubMedCrossRef
37.
Zurück zum Zitat Cromheecke M. Oral anticoagulation self management and management by a specialist anticoagulant clinic: a randomized cross-over comparison. Lancet 2000; 356: 97–102PubMedCrossRef Cromheecke M. Oral anticoagulation self management and management by a specialist anticoagulant clinic: a randomized cross-over comparison. Lancet 2000; 356: 97–102PubMedCrossRef
38.
Zurück zum Zitat Pilotto A, Franceschi M, Leandro G, et al. Geriatric Gastroenterology Study Group (Societe Italiana Gerontologie Geriatria). NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701–10PubMedCrossRef Pilotto A, Franceschi M, Leandro G, et al. Geriatric Gastroenterology Study Group (Societe Italiana Gerontologie Geriatria). NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701–10PubMedCrossRef
39.
Zurück zum Zitat Antiplatelet Trialist’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106CrossRef Antiplatelet Trialist’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106CrossRef
40.
Zurück zum Zitat The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mgr aspirin as secondary prophylaxis after cerebrovascular events. Lancet 1991; 338: 1345–53CrossRef The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mgr aspirin as secondary prophylaxis after cerebrovascular events. Lancet 1991; 338: 1345–53CrossRef
41.
Zurück zum Zitat Weil J, Colin Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827–30PubMedCrossRef Weil J, Colin Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827–30PubMedCrossRef
42.
Zurück zum Zitat Serrano P, Lanas A, Arroyo MT, et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16: 1945–53PubMedCrossRef Serrano P, Lanas A, Arroyo MT, et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16: 1945–53PubMedCrossRef
43.
Zurück zum Zitat Pilotto A, Franceschi M, Longo MG, et al. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Dig Liver Dis 2004; 36: 666–70PubMedCrossRef Pilotto A, Franceschi M, Longo MG, et al. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Dig Liver Dis 2004; 36: 666–70PubMedCrossRef
44.
Zurück zum Zitat Pilotto A, Franceschi M, Leandro G, et al. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs. Age Ageing 2004; 33: 402–4PubMedCrossRef Pilotto A, Franceschi M, Leandro G, et al. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs. Age Ageing 2004; 33: 402–4PubMedCrossRef
46.
Zurück zum Zitat Corsonello A, Pedone C, Corica F, et al. Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790–5PubMedCrossRef Corsonello A, Pedone C, Corica F, et al. Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790–5PubMedCrossRef
47.
Zurück zum Zitat Pahor M, Guralnik JM, Gambassi G, et al. The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell’ Anziano. J Clin Epidemiol 1993; 46: 1305–14PubMedCrossRef Pahor M, Guralnik JM, Gambassi G, et al. The impact of age on risk of adverse drug reactions to digoxin. For The Gruppo Italiano di Farmacovigilanza nell’ Anziano. J Clin Epidemiol 1993; 46: 1305–14PubMedCrossRef
48.
Zurück zum Zitat Juurlink DN, Mamdani M, Koop A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–8PubMedCrossRef Juurlink DN, Mamdani M, Koop A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–8PubMedCrossRef
49.
Zurück zum Zitat Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 280–5PubMedCrossRef Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 280–5PubMedCrossRef
Metadaten
Titel
Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to a Geriatric Unit
A Prospective Study of 1756 Patients
verfasst von
Marilisa Franceschi
Carlo Scarcelli
Valeria Niro
Davide Seripa
Anna Maria Pazienza
Giovanni Pepe
Anna Maria Colusso
Luigi Pacilli
Dr Alberto Pilotto
Publikationsdatum
01.06.2008
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 6/2008
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200831060-00009

Weitere Artikel der Ausgabe 6/2008

Drug Safety 6/2008 Zur Ausgabe